Except for sipuleucel-T (dendritic cell-based) and PROSTVAC-VF (PSA-based), GVAX is another vaccine indicated for PCa, consisting of inactivated PCa cell lines (PC-3, LNCaP) that could secrete GM-CSF and be effective in tumor antigen presentation. The gene discussed is CSF2; the disease is posterior cortical atrophy.